Soranib Tablet

Soranib Tablet Specification

Dosage Form
Tablet

Indication
Used for the treatment of advanced renal cell carcinoma and hepatocellular carcinoma (liver cancer)

Salt Composition
Sorafenib 200 mg

Enzyme Types
Soranib Tablet

Feature
Oral administration, targeted therapy

Application
Anticancer medication

Physical Color/Texture
Light yellow, film-coated tablet

Fermentation Smell
Odorless

Storage Instructions
Cool & Dry Place

Shelf Life
24 months

Packaging Type
Blister pack

Regulatory Approval
WHO-GMP, approved by Indian regulatory authorities

Route of Administration
Oral

Patient Advice
Use only under medical supervision

Pack Size
30 tablets per pack

Colour Marking
Engraved with identification number

Strength
200 mg

Prescription Required
Yes

ATC Classification
L01XE05

Soranib Tablet Trade Information

Minimum Order Quantity
5000 Pieces

Supply Ability
100 Pieces Per Day

Delivery Time
3-4 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Soranib Tablet

Sorafenib Tablet is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer(hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.
Yes! I am interested

Targeted Cancer Therapy

Soranib Tablet offers a specialized approach to cancer treatment, focusing on advanced kidney and liver cancers. Utilizing Sorafenib, this therapy disrupts cancer cell growth mechanisms. Its oral form provides convenience, while the targeted action limits damage to healthy cells compared to some traditional chemotherapies.

Safe and Regulated Use

Manufactured according to WHO-GMP norms and approved by Indian authorities, Soranib ensures high safety and quality standards. It is distributed in secure blister packs, each tablet engraved for authentication. The medication should only be used as directed by a qualified healthcare professional.

Patient Guidance and Storage

Patients are strongly advised to use Soranib Tablet strictly under medical supervision. The tablets should be stored in a cool, dry place away from direct sunlight to preserve efficacy and extend shelf life. Regular consultation with healthcare providers maximizes benefits and safety.

FAQ's of Soranib Tablet:

Q: How should Soranib 200 mg Tablets be taken for optimal effectiveness?

A: Soranib Tablets should be taken orally as prescribed by your doctor, usually once or twice daily. Swallow the tablet whole with water, without crushing or breaking it. Follow your doctor's instructions closely to maintain consistent drug levels in your body and optimize treatment benefits.

Q: What conditions is Soranib 200 mg Tablet indicated for?

A: Soranib is primarily used for the treatment of advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer). It is specifically recommended for patients whose cancer has spread or is not amenable to surgical intervention.

Q: When is it necessary to consult your doctor while taking Soranib Tablets?

A: You should consult your doctor before starting Soranib and regularly during treatment. If you experience side effects, allergic reactions, or worsening symptoms, contact your healthcare provider immediately. Continuous medical oversight is essential for safe and effective therapy.

Q: Where should Soranib Tablets be stored to maintain their potency?

A: Store Soranib Tablets in a cool, dry place away from direct sunlight and moisture. Ensure they are kept out of reach of children and never use the medication past its expiration date, which is 24 months from the manufacturing date.

Q: What is the process for obtaining Soranib 200 mg Tablets?

A: Soranib Tablets are a prescription-only medication. To obtain them, patients must see a qualified healthcare provider who will assess their suitability and issue a prescription. The tablets can then be purchased from authorized pharmacies or licensed exporters, primarily in India.

Q: What are the main benefits of using Soranib Tablet in cancer therapy?

A: Soranib offers targeted action against cancer cells, helping slow the progression of advanced kidney and liver cancers. Its oral administration improves patient convenience, and its formulation adheres to international safety and quality standards, providing an effective treatment option with manageable side effects.

Q: How can the patient ensure safe usage of Soranib Tablets?

A: Always use Soranib under strict medical supervision. Avoid self-medicating or altering the prescribed dose. Inform your healthcare provider about any other medications you are taking and report side effects promptly to ensure the best possible outcomes.

Tell us about your requirement